Skip to main content
Log in

Methods of Economic Evaluation for the German Statutory Healthcare System

  • Correspondence
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Dong H. Methods of economic evaluation for the German Statutory Healthcare System. Pharmacoeconomics 2009; 27 (1): 1–4

    Article  PubMed  Google Scholar 

  2. Institute for Quality and Efficiency in Health Care (IQWiG). Methods for assessment of the relation of benefits to costs in the German statutory health care system. Cologne: IQWiG, 2008 [online]. Available from URL: http://iqwig.de/index.805.html

  3. von der Schulenburg J, Vauth C, Mittendorf T, et al. Methods for determining cost-benefit ratios for pharmaceuticals in Germany. Eur J Health Econ 2007 Sep; 8 Suppl. 1: S5–31

    Article  Google Scholar 

  4. Graf von der Schulenburg JM, Greiner W, Jost F, et al., the Hanover Consensus Group. German recommendations on health economic evaluation: third and updated version of the Hanover consensus. Value Health 2008; 11 (4): 539–44

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mittendorf, T., Greiner, W. & von der Schulenburg, JM. Methods of Economic Evaluation for the German Statutory Healthcare System. Pharmacoeconomics 27, 265 (2009). https://doi.org/10.2165/00019053-200927030-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-200927030-00009

Keywords

Navigation